What is the safety and efficacy of administering lorazepam (Ativan) injectable orally to a 1-year-old patient experiencing seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Administration of Injectable Lorazepam for Seizures in a 1-Year-Old is NOT Recommended

Injectable lorazepam should never be given orally to a 1-year-old child experiencing seizures, as this route is contraindicated in the acute seizure setting due to aspiration risk and lack of efficacy data. 1

Why Oral Administration is Contraindicated

  • Nothing should be given by mouth to a patient who has just had a seizure due to decreased responsiveness and high aspiration risk in the immediate postictal period 2, 1
  • The American Academy of Pediatrics explicitly states that oral lorazepam is NOT used for acute post-seizure management—intravenous or intramuscular routes are the standard of care for seizure emergencies 1
  • Oral administration has no established efficacy or safety data for acute seizure management in pediatric patients 1

Appropriate Routes for Lorazepam in a 1-Year-Old with Seizures

First-Line: Intravenous Administration

  • Standard IV dose: 0.1 mg/kg (maximum 4 mg per dose) for status epilepticus 1, 3
  • May be repeated every 10-15 minutes if seizures persist 1
  • Intravenous lorazepam is established as efficacious for stopping seizures lasting at least 5 minutes in children (Level A evidence) 3

Alternative When IV Access Unavailable: Intramuscular Route

  • IM dose: 0.2 mg/kg (maximum 6 mg per dose) when IV access is unavailable 1
  • Can be repeated every 10-15 minutes 1
  • Intramuscular midazolam has been shown superior to IV lorazepam when IV access is not established, though direct IM lorazepam data is more limited 3

Other Non-Oral Alternatives

  • Intranasal lorazepam: 0.1 mg/kg has been shown non-inferior to IV lorazepam in children aged 6-14 years 4
  • Buccal midazolam is probably effective (Level B evidence) and preferred over rectal routes due to ease of administration 3, 5
  • Rectal diazepam is an acceptable alternative but has slower absorption 6, 3

Critical Safety Monitoring

  • Respiratory support must be immediately available regardless of route, with continuous oxygen saturation monitoring 1
  • Risk of apnea is increased, especially when combined with other sedatives 1
  • Monitor for seizure recurrence for at least 2 hours after initial lorazepam administration 1

When to Activate Emergency Medical Services

Call EMS immediately for: 2, 1

  • First-time seizure in any child
  • Seizure lasting >5 minutes
  • Multiple seizures without return to baseline between episodes
  • Seizure in an infant <6 months of age
  • Patient not returning to baseline within 5-10 minutes after seizure stops
  • Seizure with traumatic injury, difficulty breathing, or occurring in water

Subsequent Management if Seizures Persist

  • Lorazepam is rapidly redistributed and seizures often recur within 15-20 minutes, necessitating long-acting anticonvulsant coverage 1
  • If seizures persist after lorazepam, immediately administer a long-acting anticonvulsant such as phenytoin (18 mg/kg IV over 20 minutes) or fosphenytoin (20 mg phenytoin equivalents/kg at ≤150 mg/min) 1
  • If seizures continue after benzodiazepine and phenytoin/fosphenytoin, consider phenobarbital (15-20 mg/kg IV over 10 minutes) 1

Common Pitfalls to Avoid

  • Never restrain the seizing child 2
  • Never put anything in the mouth during or immediately after a seizure 2, 1
  • Do not give food, liquids, or oral medicines to a person experiencing a seizure or with decreased responsiveness after a seizure 2, 1
  • Do not use flumazenil to reverse sedation in seizure patients, as it will precipitate seizure recurrence 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.